Find Isosorbide Dinitrate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

0

Others

FDF DossiersDRUG PRODUCT COMPOSITIONS

203RELATED EXCIPIENT COMPANIES

324EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

Annual Reports

NA

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 87-33-2, Isordil, Sorbide nitrate, Sorbidnitrate, Nitrosorbide, Sorbitrate
Molecular Formula
C6H8N2O8
Molecular Weight
236.14  g/mol
InChI Key
MOYKHGMNXAOIAT-JGWLITMVSA-N
FDA UNII
IA7306519N

Isosorbide Dinitrate
A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action.
Isosorbide dinitrate is a Nitrate Vasodilator. The physiologic effect of isosorbide dinitrate is by means of Vasodilation.
1 2D Structure

Isosorbide Dinitrate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(3S,3aS,6R,6aS)-3-nitrooxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate
2.1.2 InChI
InChI=1S/C6H8N2O8/c9-7(10)15-3-1-13-6-4(16-8(11)12)2-14-5(3)6/h3-6H,1-2H2/t3-,4+,5-,6-/m1/s1
2.1.3 InChI Key
MOYKHGMNXAOIAT-JGWLITMVSA-N
2.1.4 Canonical SMILES
C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
2.1.5 Isomeric SMILES
C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)O[N+](=O)[O-])O[N+](=O)[O-]
2.2 Other Identifiers
2.2.1 UNII
IA7306519N
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Cardonit 40

2. Dilatrate

3. Dinitrate, Isosorbide

4. Iso Bid

5. Iso-bid

6. Isobid

7. Isodinit

8. Isoket

9. Isoket Retard 120

10. Isoket Retard-120

11. Isoket Retard120

12. Isomak R

13. Isordil

14. Isotrate

15. Nitrosorbide

16. Sorbitrate

17. Sorbonit

2.3.2 Depositor-Supplied Synonyms

1. 87-33-2

2. Isordil

3. Sorbide Nitrate

4. Sorbidnitrate

5. Nitrosorbide

6. Sorbitrate

7. Dinitrosorbide

8. Isoket

9. Dilatrate-sr

10. Sorbidilat

11. Vascardin

12. Carvasin

13. Flindix

14. Isorbid

15. Isotrate

16. Sorbonit

17. Cardis

18. Isdn

19. Carvanil

20. Cedocard

21. Claodical

22. Cornilat

23. Corosorbide

24. Difutrat

25. Dilatrate

26. Harrical

27. Iso-bid

28. Myorexon

29. Nitrosorbid

30. Nitrosorbon

31. Resoidan

32. Sorbangil

33. Sorbislo

34. Vasodilat

35. Vasorbate

36. Coronex

37. Emoper

38. Korodil

39. Lomilan

40. Maycor

41. Rigedal

42. Sorquad

43. Tinidil

44. Nosim

45. Xanyl

46. Sorbide, Dinitrate

47. Isordil Tembids

48. Rifloc Retard

49. Dinitroisosorbide

50. Cardio 10

51. Dianhydrosorbitol 2,5-dinitrate

52. D-isosorbide Dinitrate

53. Isosorbide 2,5-dinitrate

54. Isodinit

55. Isostat

56. Ibd 20

57. Isosorbidi Dinitras

58. Sorbide T.d.

59. Dinitrate D'isosorbide

60. Dinitrato De Isosorbida

61. Astridine

62. Isochron

63. D-glucitol, 1,4:3,6-dianhydro-, Dinitrate

64. Sorbidinitrate

65. Corovliss

66. Disorlon

67. Langoran

68. Sorbide

69. Sorquat

70. 1,4:3,6-dianhydrosorbitol 2,5-dinitrate

71. Iso-puren

72. 1,4:3,6-dianhydro-d-glucitol Dinitrate

73. Sorate-5

74. Sorate-10

75. Isomannide-dinitrate

76. C01da08

77. Nsc-80038

78. Isomak R

79. Cardonit 40

80. Chebi:6061

81. Sst-101

82. Dignionitrat

83. Angidil

84. Diniket

85. Frandol

86. Laserdil

87. Sorbidi Nitras

88. Eurecor

89. Dilatrate Sr

90. (3r,3as,6s,6as)-6-(nitrooxy)-hexahydrofuro[3,2-b]furan-3-yl Nitrate

91. Isomannide Dinitrate

92. Isosorbidi Nitras

93. Nsc80038

94. Iso-mack

95. D-isosorbide Dinitrate-lactose Mixture

96. Ia7306519n

97. Isoket Retard 40

98. Isd

99. Isoket Retard 120

100. Dsstox_cid_25832

101. Dsstox_rid_81160

102. Dsstox_gsid_45832

103. Isosorbide Dinitrato

104. Isosorbide Dinitrato [dcit]

105. Glucitol, 1,4:3,6-dianhydro-, Dinitrate, D-

106. Cedocard Retard

107. Isosorbidi Dinitras [inn-latin]

108. Tyb 3215

109. Diluted Isosorbide Dinitrate

110. Dinitrate D'isosorbide [inn-french]

111. Sdm No. 40

112. Sdm No. 50

113. Smr000857256

114. Isordil (tn)

115. Dinitrato De Isosorbida [inn-spanish]

116. Dilatrate-sr (tn)

117. Ccris 1910

118. Hsdb 3417

119. Sr-05000001658

120. Einecs 201-740-9

121. Nsc 80038

122. Un2907

123. (3r,3as,6s,6as)-hexahydrofuro[3,2-b]furan-3,6-diyl Dinitrate

124. Unii-ia7306519n

125. Cas-87-33-2

126. Prestwick_81

127. 1,4:3,6-dianhydro-2,5-di-o-nitro-d-glucitol

128. Ncgc00094703-01

129. Isosorbide-dinitrate

130. [(3s,3as,6r,6as)-3-nitrooxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] Nitrate

131. 1246815-45-1

132. Spectrum_000163

133. 1,4:3, 6-dianhydro-d-glucitol Dinitrate

134. Prestwick0_000714

135. Prestwick1_000714

136. Prestwick2_000714

137. Prestwick3_000714

138. Spectrum2_001069

139. Spectrum3_000600

140. Spectrum4_000025

141. Spectrum5_001057

142. 1,4:3,6-dianhydrosorbitol 2, 5-dinitrate

143. Isosorbide Dinitrate,(s)

144. Isosorbidi Dinitras Dilutes

145. Isosorbidi Dinitras Dilutus

146. Diluted-isosorbide Dinitrate

147. Ec 201-740-9

148. Isosorbide Dinitrate [usan:usp:inn:ban:jan]

149. Schembl8253

150. Chembl6622

151. Bspbio_000927

152. Bspbio_002080

153. Isosorbide Dinitrate, Diluted

154. Kbiogr_000429

155. Kbioss_000643

156. Mls001333561

157. Mls001333562

158. Divk1c_000436

159. Spectrum1500358

160. Isosorbide Dinitrate, Diluted-

161. Spbio_001058

162. Spbio_002848

163. Diluted Isosorbide Dinitrate Rs

164. Bpbio1_001021

165. Gtpl7051

166. Dtxsid0045832

167. Hms501f18

168. Kbio1_000436

169. Kbio2_000643

170. Kbio2_003211

171. Kbio2_005779

172. Kbio3_001580

173. Isosorbide Dinitrate [mi]

174. Ninds_000436

175. Hms1570o09

176. Hms1920h15

177. Hms2091p05

178. Hms2097o09

179. Hms2230c09

180. Hms3714o09

181. Isosorbide Dinitrate [inn]

182. Isosorbide Dinitrate [jan]

183. Pharmakon1600-01500358

184. Isosorbide Dinitrate [hsdb]

185. Isosorbide Dinitrate [usan]

186. Hy-b1409

187. 1,6-dianhydro-d-glucitol Dinitrate

188. Isosorbide Dinitrate [vandf]

189. Tox21_111317

190. Ccg-40110

191. Isosorbide Dinitrate [mart.]

192. Mfcd00868238

193. Nsc757080

194. Zinc18089317

195. 1,6-dianhydrosorbitol 2,5-dinitrate

196. Isosorbide Dinitrate [who-dd]

197. Akos015895227

198. Akos015960761

199. Akos015994784

200. Tox21_111317_1

201. Db00883

202. Gs-6631

203. Isosorbide Dinitrate (jp17/usp/inn)

204. Nsc-757080

205. Idi1_000436

206. Ncgc00178830-01

207. Ncgc00178830-02

208. Ncgc00178830-05

209. Ac-12153

210. D-glucitol,4:3,6-dianhydro-, Dinitrate

211. Isosorbide Dinitrate [orange Book]

212. Bidil Component Isosorbide Dinitrate

213. Isosorbide Dinitrate [usp Impurity]

214. Sbi-0051421.p003

215. Ab00513900

216. Cs-0013129

217. Diluted-isosorbide Dinitrate [who-ip]

218. Glucitol,4:3,6-dianhydro-, Dinitrate, D-

219. Isosorbide Dinitrate Component Of Bidil

220. C07456

221. D00516

222. H10018

223. Ab00052026_07

224. Glucitol, 1,4:3, 6-dianhydro-, Dinitrate, D-

225. Isosorbidi Dinitras Dilutus [who-ip Latin]

226. Q179748

227. 3,6-dianhydro-d-glucitol Dinitrate ; Dilatrate-sr

228. Sr-05000001658-1

229. Sr-05000001658-3

230. Sr-05000001658-5

231. W-104033

232. Z2433066075

233. Isosorbide Mononitrate, Diluted Impurity B [ep Impurity]

234. (3s,3as,6r,6as)-6-(nitrooxy)-hexahydrofuro[3,2-b]furan-3-yl Nitrate

235. [(3r,3as,6s,6as)-3-nitrooxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] Nitrate

236. [(3s,3as,6r,6as)-6-nitrooxy-2,3,3a,5,6,6a-hexahydrofuro[2,3-d]furan-3-yl] Nitrate

237. 54650-95-2

238. Isosorbide Dinitrate Mixture With Not <60% Lactose, Mannose, Starch Or Calcium Hydrogen Phosphate

239. Isosorbide Dinitrate Mixture With Not <60% Lactose, Mannose, Starch Or Calcium Hydrogen Phosphate [un2907] [flammable Solid]

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 236.14 g/mol
Molecular Formula C6H8N2O8
XLogP31.3
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count8
Rotatable Bond Count2
Exact Mass236.02806522 g/mol
Monoisotopic Mass236.02806522 g/mol
Topological Polar Surface Area129 Ų
Heavy Atom Count16
Formal Charge0
Complexity268
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 8  
Drug NameBidil
PubMed HealthIsosorbide Dinitrate (By mouth)
Drug ClassesAntianginal, Coronary Vasodilator
Active IngredientHydralazine hydrochloride; isosorbide dinitrate
Dosage FormTablet
RouteOral
Strength37.5mg; 20mg
Market StatusPrescription
CompanyArbor Pharms

2 of 8  
Drug NameDilatrate-sr
PubMed HealthIsosorbide Dinitrate (By mouth)
Drug ClassesAntianginal, Coronary Vasodilator
Drug LabelIsosorbide dinitrate (ISDN) is 1,4:3,6-dianhydro-D-glucitol 2,5 dinitrate, an organic nitrate whose structural formula isand whose molecular weight is 236.14. The organic nitrates are vasodilators, active on both arteries and veins. Each dilatrate-...
Active IngredientIsosorbide dinitrate
Dosage FormCapsule, extended release
RouteOral
Strength40mg
Market StatusPrescription
CompanyAuxilium Pharms

3 of 8  
Drug NameIsordil
Drug LabelIsosorbide dinitrate (ISDN) is 1,4:3,6-dianhydro-D-glucitol 2,5-dinitrate, an organic nitrate whose structural formula isand whose molecular weight is 236.14. The organic nitrates are vasodilators, active on both arteries and veins.Isosorbide dinitra...
Active IngredientIsosorbide dinitrate
Dosage FormTablet
RouteOral
Strength30mg; 5mg; 10mg; 40mg; 20mg
Market StatusPrescription
CompanyValeant Bermuda

4 of 8  
Drug NameIsosorbide dinitrate
Drug LabelIsosorbide dinitrate, an organic nitrate, is a vasodilator with effects on both arteries and veins. The chemical name for isosorbide dinitrate is 1,4:3,6-dianhydro-D-glucitol dinitrate and the compound has the following structural formula:C6H8N2O8 M....
Active IngredientIsosorbide dinitrate
Dosage FormTablet, extended release; Tablet
RouteOral
Strength30mg; 5mg; 10mg; 40mg; 20mg
Market StatusPrescription
CompanyCorepharma; Hikma Intl Pharms; Sun Pharm Inds; Sandoz; Par Pharm

5 of 8  
Drug NameBidil
PubMed HealthIsosorbide Dinitrate (By mouth)
Drug ClassesAntianginal, Coronary Vasodilator
Active IngredientHydralazine hydrochloride; isosorbide dinitrate
Dosage FormTablet
RouteOral
Strength37.5mg; 20mg
Market StatusPrescription
CompanyArbor Pharms

6 of 8  
Drug NameDilatrate-sr
PubMed HealthIsosorbide Dinitrate (By mouth)
Drug ClassesAntianginal, Coronary Vasodilator
Drug LabelIsosorbide dinitrate (ISDN) is 1,4:3,6-dianhydro-D-glucitol 2,5 dinitrate, an organic nitrate whose structural formula isand whose molecular weight is 236.14. The organic nitrates are vasodilators, active on both arteries and veins. Each dilatrate-...
Active IngredientIsosorbide dinitrate
Dosage FormCapsule, extended release
RouteOral
Strength40mg
Market StatusPrescription
CompanyAuxilium Pharms

7 of 8  
Drug NameIsordil
Drug LabelIsosorbide dinitrate (ISDN) is 1,4:3,6-dianhydro-D-glucitol 2,5-dinitrate, an organic nitrate whose structural formula isand whose molecular weight is 236.14. The organic nitrates are vasodilators, active on both arteries and veins.Isosorbide dinitra...
Active IngredientIsosorbide dinitrate
Dosage FormTablet
RouteOral
Strength30mg; 5mg; 10mg; 40mg; 20mg
Market StatusPrescription
CompanyValeant Bermuda

8 of 8  
Drug NameIsosorbide dinitrate
Drug LabelIsosorbide dinitrate, an organic nitrate, is a vasodilator with effects on both arteries and veins. The chemical name for isosorbide dinitrate is 1,4:3,6-dianhydro-D-glucitol dinitrate and the compound has the following structural formula:C6H8N2O8 M....
Active IngredientIsosorbide dinitrate
Dosage FormTablet, extended release; Tablet
RouteOral
Strength30mg; 5mg; 10mg; 40mg; 20mg
Market StatusPrescription
CompanyCorepharma; Hikma Intl Pharms; Sun Pharm Inds; Sandoz; Par Pharm

4.2 Therapeutic Uses

Vasodilator Agents

National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)


In a limited number of patients with diffuse esophageal spasm without gastroesophageal reflux, isosorbide dinitrate has been used effectively to relieve pain, dysphagia and spasm.

McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2002. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2002 (Plus Supplements)., p. 1880


Isosorbide dinitrate (in combination with cardiac glycosides and diuretics or with hydralazine) has been used effectively for the treatment of congestive heart failure or other low cardiac output states.

McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2002. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2002 (Plus Supplements)., p. 1880


...Isosorbide dinitrate shares the actions of the other nitrates and nitrites. The drug is used for the acute relief of angina pectoris, for prophylactic management in situations likely to provoke angina attacks, and for long term prophylactic management of angina pectoris.

McEvoy, G.K. (ed.). American Hospital Formulary Service- Drug Information 2002. Bethesda, MD: American Society of Health-System Pharmacists, Inc. 2002 (Plus Supplements)., p. 1880


For more Therapeutic Uses (Complete) data for ISOSORBIDE DINITRATE (9 total), please visit the HSDB record page.


4.3 Drug Warning

...Should be given cautiously in pt with glaucoma.

Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 788


Dependence and tolerance may occur during chronic use... These possible consequences, as well as large individual variations in clinical response indicates that long-term therapy with high-dose isosorbide dinitrate requires considerable caution.

Miller, R. R., and D. J. Greenblatt. Handbook of Drug Therapy. New York: Elsevier North Holland, 1979., p. 321


Drug rash is occasionally produced by all organic nitrates... /organic nitrates/

Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 850


Most frequent complaint by users...is headache ... also paradoxical increase in anginal pain. Mild gastrointestinal disturbances as well as vertigo and other signs of orthostatic hypotension may occur.

Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 788


For more Drug Warnings (Complete) data for ISOSORBIDE DINITRATE (10 total), please visit the HSDB record page.


4.4 Drug Indication

For the prevention of angina pectoris due to coronary artery disease.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Isosorbide Dinitrate is a moderate to long acting oral organic nitrate used for the relief and prophylactic management of angina pectoris. It relaxes the vascular smooth muscle and consequent dilatation of peripheral arteries and veins, especially the latter. Dilatation of the veins promotes peripheral pooling of blood and decreases venous return to the heart, thereby reducing left ventricular end- diastolic pressure and pulmonary capillary wedge pressure (preload). Arteriolar relaxation reduces systemic vascular resistance, systolic arterial pressure, and mean arterial pressure.


5.2 MeSH Pharmacological Classification

Vasodilator Agents

Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)


Nitric Oxide Donors

A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
ISOSORBIDE DINITRATE
5.3.2 FDA UNII
IA7306519N
5.3.3 Pharmacological Classes
Nitrates [CS]; Vasodilation [PE]; Nitrate Vasodilator [EPC]
5.4 ATC Code

C01DA08

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355


C - Cardiovascular system

C01 - Cardiac therapy

C01D - Vasodilators used in cardiac diseases

C01DA - Organic nitrates

C01DA08 - Isosorbide dinitrate


C - Cardiovascular system

C05 - Vasoprotectives

C05A - Agents for treatment of hemorrhoids and anal fissures for topical use

C05AE - Muscle relaxants

C05AE02 - Isosorbide dinitrate


5.5 Absorption, Distribution and Excretion

Absorption

Absorption of isosorbide dinitrate after oral dosing is nearly complete, but bioavailability is highly variable (10% to 90%), with extensive first-pass metabolism in the liver. The average bioavailability of isosorbide dinitrate is about 25%.


Volume of Distribution

2 to 4 L/kg


After sublingual admin, onset of effect is 2-3 min & offset of effect is about 2 hr.

Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 788


Following sublingual doses of 5 mg, oral conventional tablets of 5 mg, and oral sustained-release tablets of 20 mg, mean peak isosorbide dinitrate levels of 8.9, 3.1, and 1.4 ng/ml, occurred at 30, 40, and 40 min respectively. Plasma levels...after sustained-release dosage...maintained above half of mean peak level for 10 hours.

The Chemical Society. Foreign Compound Metabolism in Mammals. Volume 5: A Review of the Literature Published during 1976 and 1977. London: The Chemical Society, 1979., p. 40


Chronic oral administration of isosorbide dinitrate (120 to 720 mg daily) has resulted in persistence of parent compound and higher concentration of metabolite in plasma.

Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 852


Since denitration markedly reduces activity of organic nitrates, their rapid clearance from blood indicates that transient duration of action under these conditions correlates with concentration of parent compounds. /organic nitrates/

Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 849


For more Absorption, Distribution and Excretion (Complete) data for ISOSORBIDE DINITRATE (13 total), please visit the HSDB record page.


5.6 Metabolism/Metabolites

Hepatic


After intravenous or oral admin, primary metabolite in plasma is 5-isosorbide mononitrate.

Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 849


Major route of metabolism of isosorbide dinitrate in man is also by enzymatic denitration followed by formation of glucuronides.

Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 849


Biotransformation of organic nitrates is result of reductive hydrolysis catalyzed by hepatic enzyme glutathione-organic nitrate reductase. Enzyme converts lipid-soluble organic nitrate esters into more water-soluble denitrated metabolites & inorganic nitrite. /organic nitrates/

Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 848


...Biotransformation of isosorbide dinitrate in dogs and in man caused de-esterification. Isosorbide is major urinary metabolite, together with very small amount of the 2- and 5-mononitrates. /isosorbide dinitrate/ was absent from urine of dogs & man.

The Chemical Society. Foreign Compound Metabolism in Mammals. Volume 1: A Review of the Literature Published Between 1960 and 1969. London: The Chemical Society, 1970., p. 137


For more Metabolism/Metabolites (Complete) data for ISOSORBIDE DINITRATE (8 total), please visit the HSDB record page.


5.7 Biological Half-Life

1 hour


Half-life 0.7 hours (0.6-2.0; clearance may be decreased and half-life prolonged after chronic dosing.) /from table/

Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 1971


The mean plasma elimination half-life of ISMN is approx 5 hr. /Isosorbide mononitrate/

Medical Economics Co; Physicians Desk Reference 56th ed p.1827 (2002)


After sublingual admin... biological half-life is about 8 hr... .

Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 788


Biological half-life is about 8 hr; after oral admin, onset is about 30 min & offset 4-6 hr.

Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 788


5.8 Mechanism of Action

Isosorbide dinitrate is converted to the active nitric oxide to activate guanylate cyclase. This activation increases levels of cyclic guanosine 3',5'-monophosphate (cGMP). cGMP activates protein kinases and causes a series of phosphorylation reactions which leads to dephosphorylation of myosin light chains of smooth muscle fibres. Finally there is a release of calcium ions which causes smooth muscle relaxation and vasodilation.


...Nitrates...are capable of activating guanylate cyclase and causing marked increase in concentration of cyclic guanosine 3',5'-monophosphate (cyclic GMP) in most tissues. This effect is apparently due to action of nitric oxide...nitric acid probably activates the enzyme directly. /organic nitrates/

Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 848


Isosorbide dinitrate inhibited platelet aggregation with collagen, epinephrine, arachidonate, and ionophore, and blocked both primary and secondary aggregation in response to ADP.

SCHAFER AI ET AL; BLOOD 55(4) 649 (1980)


API SUPPLIERS

read-more
read-more

01

Tenatra Exports

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Tenatra

02

Lunan Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Lunan Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

03

Kremers Urban Pharmaceuticals

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Kremers Urban Pharmaceuticals

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

04

DOTTIKON EXCLUSIVE SYNTHESIS AG

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

DOTTIKON EXCLUSIVE SYNTHESIS AG

Switzerland

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF arrow-down EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT arrow-down
blank

05

Dipharma

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Dipharma

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF arrow-down VMF Others AUDIT arrow-down
blank

06

Lusochimica

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Lusochimica

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

07

Nitto Denko Avecia

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Nitto Denko Avecia

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

Nitto Denko Avecia

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Nitto Denko Avecia

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Stuart Therapeutics

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Stuart Therapeutics

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Industriale Chimica

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AACR Annual meeting
Not Confirmed
arrow

Industriale Chimica

Italy

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AACR Annual meeting
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

Dipharma Francis Srl

Italy

USDMF

arrow
AACR Annual meeting
Not Confirmed

01

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2016-06-15

Pay. Date : 2016-02-25

DMF Number : 3725

Submission : 1980-02-07

Status : Active

Type : II

blank

02

AACR Annual meeting
Not Confirmed

02

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 2663

Submission : 1976-05-07

Status : Active

Type : II

blank

03

Lusochimica Spa

Italy

USDMF

arrow
AACR Annual meeting
Not Confirmed

03

AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 2713

Submission : 1976-07-22

Status : Inactive

Type : II

blank

04

Avecia Inc

U.S.A

USDMF

arrow
AACR Annual meeting
Not Confirmed

04

Avecia Inc

U.S.A
arrow
AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 345

Submission : 1959-09-10

Status : Inactive

Type : II

blank

05

AACR Annual meeting
Not Confirmed

06

Sanol Schwarz

Country

USDMF

arrow
AACR Annual meeting
Not Confirmed

06

Sanol Schwarz

Country
arrow
AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 4224

Submission : 1981-07-22

Status : Inactive

Type : II

blank

07

Nysco Labs Inc

Country

USDMF

arrow
AACR Annual meeting
Not Confirmed

07

Nysco Labs Inc

Country
arrow
AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 1021

Submission : 1967-01-12

Status : Inactive

Type : II

blank

08

Bofors Inds

Country

USDMF

arrow
AACR Annual meeting
Not Confirmed

08

Bofors Inds

Country
arrow
AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 2238

Submission : 1974-03-01

Status : Inactive

Type : II

blank

09

Napp-lemke Chems Inc

Country

USDMF

arrow
AACR Annual meeting
Not Confirmed

09

Napp-lemke Chems Inc

Country
arrow
AACR Annual meeting
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 1791

Submission : 1971-09-13

Status : Inactive

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.

Flag India
Digital Content Digital Content

Isosorbide Dinitrate

About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...

Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opportunities grew, it was felt that the proprietorship firm had outlived its usefulness and that it needed a corporate structure. So, Tenatra Exports Private Limited was incorporated in 2002. Since then, the company has come a long way, gaining valuable experience and knowledge in the fields of chemicals and pharmaceuticals in India. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Tenatra

02

Dipharma

Italy
AACR Annual meeting
Not Confirmed
arrow

Dipharma

Italy
arrow
AACR Annual meeting
Not Confirmed

Isosorbide Dinitrate

About the Company : Dipharma is a leading European manufacturer of Active Pharmaceutical Ingredients that has been developing innovative and proprietary processes since 1949. We support our custome...

Dipharma is a leading European manufacturer of Active Pharmaceutical Ingredients that has been developing innovative and proprietary processes since 1949. We support our customers worldwide with a strong and well resourced R&D team, three cGMP facilities in Europe, and offer world-renowned expertise in handling hazardous chemical processes. Our customers can benefit from our broad portfolio of generic Active Pharmaceutical Ingredients and a wide range of advanced technologies available for custom synthesis. They can rely on the highest quality standards, but it does not stop there, they can count on our experience in innovation.
blank

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Isosorbide Dinitrate

About the Company : DOTTIKON EXCLUSIVE SYNTHESIS, (Aargau, Switzerland), specializes on hazardous chemistry, low-temperature and high-pressure as well as continuous processing, and focuses on the excl...

DOTTIKON EXCLUSIVE SYNTHESIS, (Aargau, Switzerland), specializes on hazardous chemistry, low-temperature and high-pressure as well as continuous processing, and focuses on the exclusive synthesis of fine chemicals for the pharmaceutical and chemical industry worldwide. If you have a hazardous chemical problem, Dottikon can offer a solution.
blank

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Isosorbide Dinitrate

About the Company : The IQT is a Brazilian chemical industry, with 100% national capital, and that is a competitive position among the largest companies in the research and development of various mate...

The IQT is a Brazilian chemical industry, with 100% national capital, and that is a competitive position among the largest companies in the research and development of various materials of industrial application. Throughout our history, we have been responsible for developing the country and pharmochemical new chemical solutions that add value and quality of life for its consumers.
blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Isosorbide Dinitrate

About the Company : Jinzhou Jiutai Pharmaceutical is a comprehensive pharmaceutical enterprise which has more than 60 years manufacturing history. It was set up in 1951. There are 5 workshops, one res...

Jinzhou Jiutai Pharmaceutical is a comprehensive pharmaceutical enterprise which has more than 60 years manufacturing history. It was set up in 1951. There are 5 workshops, one research institute, and 620 staff members, including 310 technical personnel. The company owns advanced production technology, mature process route and complete system for quality inspection and control.
blank

06

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Isosorbide Dinitrate

About the Company : J P Laboratories Pvt. Ltd., located in Kurkumbh MIDC (80 km from Pune on Solapur Highway), specializes in manufacturing Active Pharmaceutical Ingredients (APIs). Nestled at A-76, M...

J P Laboratories Pvt. Ltd., located in Kurkumbh MIDC (80 km from Pune on Solapur Highway), specializes in manufacturing Active Pharmaceutical Ingredients (APIs). Nestled at A-76, MIDC Kurkumbh, Taluka Daund, District Pune, the facility benefits from strategic proximity to industry leaders: Suyash Organics (north), Glenmark Generics (west), Ramkamal Industries (south), and well-connected roads (east). This positioning enhances logistics, fosters collaboration, and creates an ideal environment for pharmaceutical production.
blank

07

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Isosorbide Dinitrate

About the Company : Lunan Pharmaceutical Group is an integrated pharmaceutical group setting production, scientific research and sale of traditional Chinese medicines, chemicals, biological products i...

Lunan Pharmaceutical Group is an integrated pharmaceutical group setting production, scientific research and sale of traditional Chinese medicines, chemicals, biological products in one, a national innovative enterprise, China Torch Program key high-tech enterprise. The group is composed of seven subsidiary enterprises including Lunan Hope Pharmaceutical Co., Ltd., Lunan Better Pharmaceutical Co., Ltd., Shandong New Time Pharmaceutical Co., Ltd., Lunan New Time Bio-Tech Co., Ltd., etc. It has been awarded the Top 500 Chinese Large Enterprise Group Competitiveness and Top 100 Taxpayers in Shandong Province for consecutive years.
blank

08

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Isosorbide Dinitrate

About the Company : QINGDAO QINGMEI BIOTECH(hereinafter referred to as Qingmei) is a specialized pharmaceutical company founded by DAYON INTERNATIONAL HOLDING LIMITED, which is to expand international...

QINGDAO QINGMEI BIOTECH(hereinafter referred to as Qingmei) is a specialized pharmaceutical company founded by DAYON INTERNATIONAL HOLDING LIMITED, which is to expand international business and strategic cooperation with suppliers. The company is located in the beautiful coastal city of Qingdao, near City Hall and the May Fourth Square, and also close to the port, so that it has convenient traffic conditions for trade. The company's business focuses on the development and promotion of the pharmaceutical chemicals, animal health, food additives, plant extracts, cosmetic raw materials, intermediates and other fine chemicals.
blank

09

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Isosorbide Dinitrate

About the Company : Xi’an Libang Enterprises, established in 1996, a hi-tech biopharmaceutical-oriented corporate group specialized in the development, production and distribution of pharmaceutical ...

Xi’an Libang Enterprises, established in 1996, a hi-tech biopharmaceutical-oriented corporate group specialized in the development, production and distribution of pharmaceutical products and healthy nutrition products, also presenting in the cultural industry. Libang Group, with Xi’an Libang Holdings Ltd. as the parent company, divided into Libang Pharmaceutical Group, Healthy Nutrition Group and other wholly owned subsidiaries engaged in culture, financial, property etc, totally over 1000 employees.
blank

10

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Isosorbide Dinitrate

About the Company : Incepted in 1989, Zim has made a significant mark as a maverick pharma innovator. Throughout all these years constantly penetrating newer areas of pharmaceutical technology and bus...

Incepted in 1989, Zim has made a significant mark as a maverick pharma innovator. Throughout all these years constantly penetrating newer areas of pharmaceutical technology and business, Zim has established itself as one of the preferred healthcare solution provider in the field of new drug delivery systems. Headquartered in central India, in the industrial belt of Nagpur, we are a WHO GMP certified and ISO 9001:2008 accredited company supported by an excellent team of professionals and we have sufficient capacity to meet large requirements for different market segments. We are engaged in research and development, manufacturing, distribution and marketing of pharmaceutical dosage forms such as tablets, capsules, pellets, multi-particulate systems, dry syrups, directly compressible granules, taste masked powders, granules and orally disintegrating strips. At Zim we believe in constant innovation. We have earned appreciation for quality products and prompt services by domestic and international clients. Our business strategy is to innovate and deliver high-throughput technology based niche products. Zim is known in diverse, high-growth, niche markets, for institutional and pre-formulation intermediate businesses.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more
  • Development Update

Details:

Furosemide is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Heart Failure.


Lead Product(s): Furosemide,Torsemide,Bumetanide,Sacubitril-Valsartan,Hydralazine,Isosorbide Dinitrate

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Boston Scientific

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 23, 2024

blank

01

Heart Center Research, LLC

Country
arrow
AACR Annual meeting
Not Confirmed

Heart Center Research, LLC

Country
arrow
AACR Annual meeting
Not Confirmed

Details : Furosemide is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Heart Failure.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

January 23, 2024

blank

Details:

In accordance with this agreement TOA EIYO will independently sell and provide information on all 18 products such as Bisono® tape for treatment of hypertension and atrial fibrillation and Frandol® tablets and tape for treatment of ischemic heart disease.


Lead Product(s): Isosorbide Dinitrate,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Frandol

Study Phase: Approved FDFProduct Type: Miscellaneous

Sponsor: Astellas Pharma

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Termination April 05, 2021

blank

02

TOA EIYO

Japan
arrow
AACR Annual meeting
Not Confirmed

TOA EIYO

Japan
arrow
AACR Annual meeting
Not Confirmed

Details : In accordance with this agreement TOA EIYO will independently sell and provide information on all 18 products such as Bisono® tape for treatment of hypertension and atrial fibrillation and Frandol® tablets and tape for treatment of ischemic heart disea...

Product Name : Frandol

Product Type : Miscellaneous

Upfront Cash : Undisclosed

April 05, 2021

blank

Details:

Isosorbide Dinitrate is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Heart Failure.


Lead Product(s): Isosorbide Dinitrate,Hydralazine

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 13, 2015

blank

03

AACR Annual meeting
Not Confirmed
AACR Annual meeting
Not Confirmed

Details : Isosorbide Dinitrate is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Heart Failure.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

August 13, 2015

blank
  • Development Update

Details:

Hydralazine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Heart Failure.


Lead Product(s): Hydralazine,Isosorbide Dinitrate

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Momentum Research Inc

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 02, 2013

blank

04

University of Cape Town

Country
arrow
AACR Annual meeting
Not Confirmed

University of Cape Town

Country
arrow
AACR Annual meeting
Not Confirmed

Details : Hydralazine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Heart Failure.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

April 02, 2013

blank

Details:

Isosorbide Dinitrate is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.


Lead Product(s): Isosorbide Dinitrate,Hydralazine

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: Phase IProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 30, 2012

blank

05

AACR Annual meeting
Not Confirmed
AACR Annual meeting
Not Confirmed

Details : Isosorbide Dinitrate is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

April 30, 2012

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Isosorbide Dinitrate

Brand Name : Isordil 10 mg

Dosage Form : TAB

Dosage Strength : 10mg

Packaging : 50X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

02

Isosorbide Dinitrate

Brand Name : Isordil 10 mg

Dosage Form : TAB

Dosage Strength : 10mg

Packaging : 500X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

03

Isosorbide Dinitrate

Brand Name : Isordil

Dosage Form : TAB

Dosage Strength : 30mg

Packaging : 50X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

04

Isosorbide Dinitrate

Brand Name : Isordil

Dosage Form : TAB

Dosage Strength : 5mg

Packaging : 50X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

05

Isosorbide Dinitrate

Brand Name : Isordil 40 mg

Dosage Form : TAB

Dosage Strength : 40mg

Packaging : 30X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

06

Isosorbide Dinitrate

Brand Name : Isordil 40 mg

Dosage Form : TAB

Dosage Strength : 40mg

Packaging : 100X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Aspen API Comapny Banner

07

Isosorbid Dinitrate

Brand Name : Cardopax Retard

Dosage Form : Prolonged-Release Tablet

Dosage Strength : 40mg

Packaging :

Approval Date : 07-02-1985

Application Number : 28101184184

Regulatory Info : Prescription

Registration Country : Denmark

Fermion Orion Company Banner

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Hydralazine Hydrochloride; Isosorbide Dinitrate

Brand Name : Hydralazine Hydrochloride; Isosorbide Dinitrate

Dosage Form : Tablet

Dosage Strength : 20MG; 37.7MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Flag India
Digital Content Digital Content

Regulatory Info :

Registration Country : India

Isosorbide Dinitrate

Brand Name : Isosorbide Dinitrate

Dosage Form : Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

10

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

ISOSORBIDE DINITRATE

Brand Name : ISORDIL

Dosage Form : TABLET;ORAL

Dosage Strength : 40MG

Packaging :

Approval Date : 1988-07-29

Application Number : 12093

Regulatory Info : RX

Registration Country : USA

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

Isosorbid Dinitrate

Brand Name : Cardopax Retard

Dosage Form : Prolonged-Release Tablet

Dosage Strength : 40mg

Packaging :

Approval Date : 07-02-1985

Application Number : 28101184184

Regulatory Info : Prescription

Registration Country : Denmark

Fermion Orion Company Banner

02

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Isosorbide Dinitrate

Brand Name : Isosorbide Dinitrate

Dosage Form : Tablet

Dosage Strength : 10MG

Packaging :

Approval Date : 2012-03-23

Application Number :

Regulatory Info : Withdrawn

Registration Country : Malta

blank

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

Isosorbide Dinitrate

Brand Name : Pensordil

Dosage Form : Tablet

Dosage Strength : 10MG

Packaging :

Approval Date : 2007-02-01

Application Number :

Regulatory Info : Withdrawn

Registration Country : Malta

blank

04

Norgine Ag

Netherlands
AACR Annual meeting
Not Confirmed
arrow

Norgine Ag

Netherlands
arrow
AACR Annual meeting
Not Confirmed

Isosorbide Dinitrate

Brand Name : Isoket

Dosage Form : Sublingual Tablet

Dosage Strength : 5mg

Packaging :

Approval Date : 08/01/1982

Application Number : 38470

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

Norgine Ag

Netherlands
AACR Annual meeting
Not Confirmed
arrow

Norgine Ag

Netherlands
arrow
AACR Annual meeting
Not Confirmed

Isosorbide Dinitrate

Brand Name : Isoket retard

Dosage Form : Sustained Release Capsule

Dosage Strength : 120mg

Packaging :

Approval Date : 30/12/1983

Application Number : 45979

Regulatory Info : Allowed

Registration Country : Switzerland

blank

06

UCB PHARMA SpA

Belgium
AACR Annual meeting
Not Confirmed
arrow

UCB PHARMA SpA

Belgium
arrow
AACR Annual meeting
Not Confirmed

Isosorbide Dinitrate

Brand Name : Diniket

Dosage Form : Isosorbide Dinitrate 10Mg 10Ml 10 Units Parenteral Use

Dosage Strength : 10 VIALS EV 10 mg 10 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

IST.LUSOFARMACO D'ITALIA SpA

Country
AACR Annual meeting
Not Confirmed
arrow

IST.LUSOFARMACO D'ITALIA SpA

Country
arrow
AACR Annual meeting
Not Confirmed

Isosorbide Dinitrate

Brand Name : Nitrorbide

Dosage Form : Isosorbide Dinitrate 10Mg 50 Combined Oral Use

Dosage Strength : 50 CPR 10 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

08

TEOFARMA Srl

Country
AACR Annual meeting
Not Confirmed
arrow

TEOFARMA Srl

Country
arrow
AACR Annual meeting
Not Confirmed

Isosorbide Dinitrate

Brand Name : Carvasin

Dosage Form :

Dosage Strength : 50 Cpr 10 Mg  

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

09

EJ Busuttil Ltd

Country
AACR Annual meeting
Not Confirmed
arrow

EJ Busuttil Ltd

Country
arrow
AACR Annual meeting
Not Confirmed

Isosorbide Dinitrate

Brand Name : Cedocard I.V.

Dosage Form : Solution For Infusion

Dosage Strength : 1MG/ML

Packaging :

Approval Date : 2025-01-21

Application Number :

Regulatory Info : Authorised

Registration Country : Malta

blank

10

Meda Ab

Country
AACR Annual meeting
Not Confirmed
arrow

Meda Ab

Country
arrow
AACR Annual meeting
Not Confirmed

Isosorbide Dinitrate

Brand Name : Sorbangil

Dosage Form : Tablet

Dosage Strength : 5mg

Packaging :

Approval Date : 21-11-1963

Application Number : 1.96E+13

Regulatory Info : Deregistered

Registration Country : Sweden

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL - 10MG **Federal Registe...DOSAGE - TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 12093

read-more

DOSAGE - TABLET;ORAL - 20MG **Federal Registe...DOSAGE - TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 12093

read-more

DOSAGE - TABLET;ORAL - 30MG **Federal Registe...DOSAGE - TABLET;ORAL - 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

USFDA APPLICATION NUMBER - 12093

read-more

DOSAGE - TABLET;ORAL - 40MG

USFDA APPLICATION NUMBER - 12093

read-more

DOSAGE - TABLET;ORAL - 5MG

USFDA APPLICATION NUMBER - 12093

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 40M...DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 40MG

USFDA APPLICATION NUMBER - 19790

read-more

DOSAGE - TABLET;ORAL - 37.5MG;20MG

USFDA APPLICATION NUMBER - 20727

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Controlled & Modified Release

read-more
read-more
click full view

Lubricants & Glidants

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Solubilizers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Topical

read-more
read-more

Taste Masking

read-more
read-more

Empty Capsules

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Parenteral

read-more
read-more

Emulsifying Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Vegetarian Capsules

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Coloring Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 87-33-2 / Isosorbide Dinitrate API manufacturers, exporters & distributors?

Isosorbide Dinitrate manufacturers, exporters & distributors 1

19

PharmaCompass offers a list of Isosorbide Dinitrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Isosorbide Dinitrate manufacturer or Isosorbide Dinitrate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Isosorbide Dinitrate manufacturer or Isosorbide Dinitrate supplier.

API | Excipient name

Isosorbide Dinitrate

Synonyms

87-33-2, Isordil, Sorbide nitrate, Sorbidnitrate, Nitrosorbide, Sorbitrate

Cas Number

87-33-2

Unique Ingredient Identifier (UNII)

IA7306519N

About Isosorbide Dinitrate

A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action.

Flindix Manufacturers

A Flindix manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flindix, including repackagers and relabelers. The FDA regulates Flindix manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flindix API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Flindix manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Flindix Suppliers

A Flindix supplier is an individual or a company that provides Flindix active pharmaceutical ingredient (API) or Flindix finished formulations upon request. The Flindix suppliers may include Flindix API manufacturers, exporters, distributors and traders.

click here to find a list of Flindix suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Flindix USDMF

A Flindix DMF (Drug Master File) is a document detailing the whole manufacturing process of Flindix active pharmaceutical ingredient (API) in detail. Different forms of Flindix DMFs exist exist since differing nations have different regulations, such as Flindix USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Flindix DMF submitted to regulatory agencies in the US is known as a USDMF. Flindix USDMF includes data on Flindix's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Flindix USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Flindix suppliers with USDMF on PharmaCompass.

Flindix JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Flindix Drug Master File in Japan (Flindix JDMF) empowers Flindix API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Flindix JDMF during the approval evaluation for pharmaceutical products. At the time of Flindix JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Flindix suppliers with JDMF on PharmaCompass.

Flindix KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Flindix Drug Master File in Korea (Flindix KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Flindix. The MFDS reviews the Flindix KDMF as part of the drug registration process and uses the information provided in the Flindix KDMF to evaluate the safety and efficacy of the drug.

After submitting a Flindix KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Flindix API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Flindix suppliers with KDMF on PharmaCompass.

Flindix CEP

A Flindix CEP of the European Pharmacopoeia monograph is often referred to as a Flindix Certificate of Suitability (COS). The purpose of a Flindix CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Flindix EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Flindix to their clients by showing that a Flindix CEP has been issued for it. The manufacturer submits a Flindix CEP (COS) as part of the market authorization procedure, and it takes on the role of a Flindix CEP holder for the record. Additionally, the data presented in the Flindix CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Flindix DMF.

A Flindix CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Flindix CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Flindix suppliers with CEP (COS) on PharmaCompass.

Flindix NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Flindix as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Flindix API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Flindix as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Flindix and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Flindix NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Flindix suppliers with NDC on PharmaCompass.

Flindix GMP

Flindix Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Flindix GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Flindix GMP manufacturer or Flindix GMP API supplier for your needs.

Flindix CoA

A Flindix CoA (Certificate of Analysis) is a formal document that attests to Flindix's compliance with Flindix specifications and serves as a tool for batch-level quality control.

Flindix CoA mostly includes findings from lab analyses of a specific batch. For each Flindix CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Flindix may be tested according to a variety of international standards, such as European Pharmacopoeia (Flindix EP), Flindix JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Flindix USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty